Biotech Patents in the Age of Free Trade
Chapter 9: Gene Wars
We don’t think it’s right for someone to decode genomes, perform no research and then be able to make outrageous claims. Spokesman for F Hoﬀmann-La Roche AG, Die Zeit, 36/20011 In November 2006 Michael Hopkins and other researchers at the University of Sussex published a report entitled The Patenting of Human DNA: Global Trends in Public and Private Sector Activity.2 The study that formed the basis of their report found that between 1980 and 2003 15 000 patent families (which suggests that there are tens of thousands of individual DNA patents) claiming human DNA had been granted around the world. The report’s authors would have found, had their study extended beyond human DNA, many more claiming non-human DNA, and even thousands more again claiming the cellular components involved in the production of naturally occurring proteins. Without any doubt by 2006 virtually anything that was naturally occurring but ‘isolated’ was the subject of a patent giving their owners the legal right exclusively to control their ‘inventions’ for at least 20 years. Undoubtedly the proliferation of patents over such things and the frustrating need to seek patent licences even to undertake basic research prompted a spokesman from F Hoﬀmann-La Roche AG to criticize those who ‘decode genomes’, but, given that Genentech was then a company which Roche controlled and which had been established in 1976 to do precisely that, the criticism was made either in ignorance or as part of a lie that was designed to elicit sympathy from European...
You are not authenticated to view the full text of this chapter or article.